Minerva

Minerva

BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2441 (Published 04 April 2012) Cite this as: BMJ 2012;344:e2441
  1. Jacob P Thyssen, resident in dermatology,
  2. Torkil Menné, professor,
  3. Claus Zachariae, consultant, department of dermato-allergology
  1. 1National Allergy Research Centre, Copenhagen University Hospital Gentofte, Niels Andersens Vej 65, DK-2900 Hellerup, Denmark
  1. jacpth01{at}geh.regionh.dk

One in 10 Europeans have mutations in the filaggrin gene that result in a dysfunctional skin barrier. Mutations lead …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe